Assyro AI

Orange Book product · Brand (NDA)

ACETAMINOPHEN

ACETAMINOPHEN

Brand (NDA)NDA 204767RX FRESENIUS KABI USA

At a glance

Oct 28, 2015

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 28, 2015

    10 yr 10 mo ago

  2. Today

  3. Patent 8741959 expires

    Listed drug product patent expiration.

    Apr 19, 2030

    in 3 yr 11 mo

Pharmaceutical detail

Active ingredient

ACETAMINOPHEN

Strength

1GM/100ML (10MG/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 204767

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

This is a brand (NDA) product. Other products sharing this active ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8741959Apr 19, 2030in 3 yr 11 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.